Scholarlink

<p>This study developed and evaluated the efficacy of an individual cognitive behavioral therapy for substance users with insomnia. Individual Cognitive Behavioral Therapy for Insomnia in Substance (CBT-I-SUD) was a five-session program consisting of sleep restriction, stimulus control, sleep hygiene, cognitive therapy, and relaxation techniques. Participants were recruited from a drug addiction rehabilitation center of a national forensic hospital in Korea. Twenty-nine qualified participants were randomly assigned to receive individual CBT-I-SUD (trial group, 15 participants) and individual CBT for depression–substance use disorder (CBT-D-SUD; control group, 14 participants). Sleep, substance abuse, and emotion-related outcome measures were used to evaluate the therapy. The program led to significant improvement in insomnia severity, sleep quality, craving, readiness for change, treatment eagerness, and depression. For substance users who need to be cautious about taking sleeping pills, this program is expected to have a positive effect on insomnia, preventing relapses, and controlling emotions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Development and Evaluation of Individual CBT for Insomnia in Substance Users

  • 期刊论文

  • 发表日期：

    2025年12月1日

查看全文
  • Min-A Kang,
  • Wonyoung Song,
  • Bo-Yun Park,
  • Dae-Jin Kim

摘要

This study developed and evaluated the efficacy of an individual cognitive behavioral therapy for substance users with insomnia. Individual Cognitive Behavioral Therapy for Insomnia in Substance (CBT-I-SUD) was a five-session program consisting of sleep restriction, stimulus control, sleep hygiene, cognitive therapy, and relaxation techniques. Participants were recruited from a drug addiction rehabilitation center of a national forensic hospital in Korea. Twenty-nine qualified participants were randomly assigned to receive individual CBT-I-SUD (trial group, 15 participants) and individual CBT for depression–substance use disorder (CBT-D-SUD; control group, 14 participants). Sleep, substance abuse, and emotion-related outcome measures were used to evaluate the therapy. The program led to significant improvement in insomnia severity, sleep quality, craving, readiness for change, treatment eagerness, and depression. For substance users who need to be cautious about taking sleeping pills, this program is expected to have a positive effect on insomnia, preventing relapses, and controlling emotions.